Post by
investderp on Nov 16, 2015 9:58am
Voting Question
Voting Question: Does MCNA have an overall favorable benefit-risk profile for the treatment of non-muscle invasive bladder cancer at high risk of recurrence or progression in adult patients who failed prior BCG immunotherapy, e.g., in patients who are BCG-refractory or BCG-relapsing?
Comment by
DamnYankees on Nov 16, 2015 10:03am
I am having trouble opening the link. Is this the verbatim question they will be voting on?